| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |